Literature DB >> 27118951

Polycystic Liver Disease.

.   

Abstract

Entities:  

Year:  2015        PMID： 27118951      PMCID： PMC4843043     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  10 in total

1.  A 20-year experience with liver transplantation for polycystic liver disease: does previous palliative surgical intervention affect outcomes?

Authors:  John T Baber; Jonathan R Hiatt; Ronald W Busuttil; Vatche G Agopian
Journal:  J Am Coll Surg       Date:  2014-05-23       Impact factor: 6.113

2.  Ursodeoxycholic acid inhibits hepatic cystogenesis in experimental models of polycystic liver disease.

Authors:  Patricia Munoz-Garrido; José J G Marin; María J Perugorria; Aura D Urribarri; Oihane Erice; Elena Sáez; Miriam Úriz; Sarai Sarvide; Ainhoa Portu; Axel R Concepcion; Marta R Romero; María J Monte; Álvaro Santos-Laso; Elizabeth Hijona; Raúl Jimenez-Agüero; Marco Marzioni; Ulrich Beuers; Tatyana V Masyuk; Nicholas F LaRusso; Jesús Prieto; Luis Bujanda; Joost P H Drenth; Jesús M Banales
Journal:  J Hepatol       Date:  2015-06-01       Impact factor: 25.083

3.  Management of symptomatic polycystic liver disease with hepatic resection.

Authors:  Jennifer Tseng; Susan L Orloff
Journal:  JAMA Surg       Date:  2015-01       Impact factor: 14.766

4.  Lanreotide Reduces Liver Volume, But Might Not Improve Muscle Wasting or Weight Loss, in Patients With Symptomatic Polycystic Liver Disease.

Authors:  Frederik Temmerman; Thien Ahn Ho; Ragna Vanslembrouck; Walter Coudyzer; Jaak Billen; Fabienne Dobbels; Jos van Pelt; Bert Bammens; Yves Pirson; Frederik Nevens
Journal:  Clin Gastroenterol Hepatol       Date:  2015-06-12       Impact factor: 11.382

5.  Somatostatin analogues improve health-related quality of life in polycystic liver disease: a pooled analysis of two randomised, placebo-controlled trials.

Authors:  M K Neijenhuis; T J G Gevers; F Nevens; M C Hogan; V E Torres; W Kievit; J P H Drenth
Journal:  Aliment Pharmacol Ther       Date:  2015-07-01       Impact factor: 8.171

6.  A classification of ductal plate malformations based on distinct pathogenic mechanisms of biliary dysmorphogenesis.

Authors:  Peggy Raynaud; Joshua Tate; Céline Callens; Sabine Cordi; Patrick Vandersmissen; Rodolphe Carpentier; Christine Sempoux; Olivier Devuyst; Christophe E Pierreux; Pierre Courtoy; Karin Dahan; Katty Delbecque; Sébastien Lepreux; Marco Pontoglio; Lisa M Guay-Woodford; Frédéric P Lemaigre
Journal:  Hepatology       Date:  2011-05-02       Impact factor: 17.425

7.  Everolimus does not further reduce polycystic liver volume when added to long acting octreotide: results from a randomized controlled trial.

Authors:  Melissa Chrispijn; Tom J G Gevers; Jeroen C Hol; Rene Monshouwer; Heleen M Dekker; Joost P H Drenth
Journal:  J Hepatol       Date:  2013-03-14       Impact factor: 25.083

8.  Sirolimus reduces polycystic liver volume in ADPKD patients.

Authors:  Qi Qian; Hui Du; Bernard F King; Sumedha Kumar; Patrick G Dean; Fernando G Cosio; Vicente E Torres
Journal:  J Am Soc Nephrol       Date:  2008-01-16       Impact factor: 10.121

9.  Young women with polycystic liver disease respond best to somatostatin analogues: a pooled analysis of individual patient data.

Authors:  Tom J G Gevers; Joanna Inthout; Anna Caroli; Piero Ruggenenti; Marie C Hogan; Vicente E Torres; Frederik Nevens; Joost P H Drenth
Journal:  Gastroenterology       Date:  2013-05-07       Impact factor: 22.682

Review 10.  Polycystic liver disease: an overview of pathogenesis, clinical manifestations and management.

Authors:  Wybrich R Cnossen; Joost P H Drenth
Journal:  Orphanet J Rare Dis       Date:  2014-05-01       Impact factor: 4.123
  10 in total
  1 in total

1.  Imaging in ductal plate malformations.

Authors:  Binit Sureka; Archana Rastogi; Chhagan Bihari; Kishore G S Bharathy; Vikrant Sood; Seema Alam
Journal:  Indian J Radiol Imaging       Date:  2017 Jan-Mar
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.